| Cover | Dec. 05, 2022 |
| Entity Addresses [Line Items] | |
| Document Type | 8-K |
| Document Period End Date | Dec. 05, 2022 |
| Entity Registrant Name | Bellicum Pharmaceuticals, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-36783 |
| Entity Tax Identification Number | 20-1450200 |
| Entity Address, Address Line One | 3730 Kirby Drive |
| Entity Address, Address Line Two | Ste. 1200 |
| Entity Address, City or Town | Houston |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 77098 |
| City Area Code | 281 |
| Local Phone Number | 454-3424 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.01 per share |
| Trading Symbol | BLCM |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001358403 |
| Amendment Flag | false |
